AlphAIalphai — Financial news for AI agents
StockHealthcare · Medical Distribution

$HKPD

Cellyan Biotechnology Co., Ltd

Price · $HKPDvia TradingView
AI sentiment · 7d0 articles

No enriched coverage for $HKPD in the last 7 days.

Insider · 30dFeed →

No SEC Form 4 filings for $HKPD in the last 30 days.

Top stories · $HKPDMore →
JAN 17·The Manila TimesMed

Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency

Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) has received a notice from Nasdaq regarding non-compliance with the minimum bid price requirement. The company's share price was below $1.00 for 30 consecutive business days. Cellyan Biotechnology Co., Ltd has 180 calendar days to regain compliance, with a potential additional 180-day grace period, and is currently exploring options to address the deficiency.

DEC 18·Stock Titan

Hong Kong Pharma Digital to change its name to Cellyan Biotechnology

Hong Kong Pharma Digital (NASDAQ: HKPD) announced that shareholders approved all proposals at its December 12, 2025 annual meeting, including a 10x increase in authorized share capital, a share re-designation, a reverse share split, a share repurchase, and the adoption of an Equity Incentive Plan. Critically, the company's name will change to Cellyan Biotechnology Co., Ltd. Following this news, HKPD stock declined by 4.37%, reflecting a moderate negative market reaction.

News on $HKPD

All news →